On Monday, Netflix, Inc.(NASDAQ:NFLX)’s shares declined -2.26% to $100.30.
Netflix, Inc. (NFLX) declared it will post its third-quarter 2015 financial results and business outlook on its investor relations website at http://ir.netflix.com on Wednesday, October 14, 2015, at about 1:05 p.m. Pacific Time. At that time the company will issue a brief advisory release via newswire containing a link to the third-quarter 2015 financial results and letter to shareholders on its website.
Netflix, Inc., an Internet television network, engages in the Internet delivery of TV shows and movies directly on TVs, computers, and mobile devices in the United States and internationally. The company operates in three segments: Domestic Streaming, International Streaming, and Domestic DVD.
Comcast Corporation (NASDAQ:CMCSK)’s shares gained 1.85% to $58.28.
In celebration of the World Meeting of Families – Philadelphia 2015 and the historic visit of Pope Francis to Philadelphia, Comcast recently unveiled Eternally Rome, a new 13-minute show presented on “The Comcast Experience” video wall in the Comcast Center lobby.
Eternally Rome is a visual celebration of the ancient, beautiful city, shot using stunning high-resolution cinematography and featuring breathtaking views of some of Rome’s most iconic landmarks, counting the Colosseum, Pantheon, The Roman Forum, St. Peter’s Square and Vatican City.
Brian L. Roberts, Chairman and CEO of Comcast, and Archbishop Charles J. Chaput of the Archdiocese of Philadelphia, presented the show recently to several hundred guests in the Comcast Center lobby.
Comcast Corporation operates as a media and technology company worldwide. It operates through Cable Communications, Cable Netoperates, Broadcast Television, Filmed Entertainment, and Theme Parks segments. The Cable Communications segment offers video, high-speed Internet, and voice services to residential and business customers under the XFINITY brand name.
At the end of Monday’s trade, Macy’s, Inc.(NYSE:M)‘s shares dipped -0.33% to $53.88.
In honor of Hispanic Heritage Month (Sept. 15 – Oct. 15), Macy’s (NYSE:M) celebrates Hispanic and Latino culture and accomplishments with celebrity guests Mario Lopez, Don Omar and Angel Merino, who have influenced pop culture through their music, lifestyle and beauty expertise. During exciting special events across the country, Macy’s will bring together these three influyentes to share their inspiring stories with customers in live candid conversations.
With two Latin Grammy awards under his belt, Don Omar became one of reggaeton’s first international superstars with his debut album “The Last Don” in 2003. He is also an acclaimed actor, known worldwide for his role as Rico Santos in the “The Fast and the Furious” movie franchise.
Macy’s, Inc., together with its auxiliaries, operates stores and Internet Websites in the United States. Its stores and Websites sell a range of merchandise, counting apparel and accessories for men, women, and children; cosmetics; home furnishings; and other consumer goods.
Geron Corporation (NASDAQ:GERN), ended its Monday’s trading session with -6.13% loss, and closed at $3.37.
Geron Corporation (GERN) stated financial results for the second quarter ended June 30, 2015.
Second Quarter 2015 Results
For the second quarter of 2015, the company stated a net loss of $9.4 million, or $0.06 per share, contrast to $8.7 million, or $0.06 per share, for the comparable 2014 period. Revenues for the second quarter of 2015 were $251,000 contrast to $341,000 for the comparable 2014 period. Interest and other income for the second quarter of 2015 amounted to $145,000 contrast to $99,000 for the comparable 2014 period. The company ended the second quarter of 2015 with $157.0 million in cash and investments.
Total operating expenses for the second quarter of 2015 were $9.7 million contrast to $9.0 million for the comparable 2014 period. Research and development expenses for the second quarter of 2015 were $4.8 million contrast to $5.2 million for the comparable 2014 period. General and administrative expenses for the second quarter of 2015 were $4.0 million contrast to $3.9 million for the comparable 2014 period. Operating expenses for the 2015 second quarter also comprised of restructuring charges of $941,000 in connection with the company’s organizational resizing declared in March 2015.
Geron Corporation, a clinical stage biopharmaceutical company, focuses on the development of telomerase inhibitor, imetelstat, for treating hematologic myeloid malignancies. It has partnership and license agreement with Janssen Biotech, Inc. to develop and commercialize imetelstat worldwide for indications in oncology, counting hematologic myeloid malignancies and other human therapeutic uses. The company was founded in 1990 and is based in Menlo Park, California.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
